Risk factors | Univariate analysis | P | Multivariate analysis | P |
---|---|---|---|---|
OR (95% CI) | OR (95% Cl) | |||
Female sex | 1.32 (0.97–1.79) | 0.0804 | 0.78 (0.56–1.10) | 0.1555 |
CD diagnosis | 1.59 (1.16–2.19) | 0.0044 | 0.77 (0.54–1.10) | 0.1519 |
Median IBD duration | 1.0304 (1.01–1.05) | 0.0100 | 1.03 (1.00–1.05) | 0.0259 |
Median diagnosis age | 0.9971 (0.99–1.01) | 0.5563 |  |  |
Active smokers | 1.04 (0.75–1.45) | 0.8113 |  |  |
CRP > 3 mg/dl | 1.11 (0.79–1.56) | 0.5512 |  |  |
Extensive colitis | 1.28 (0.76–2.14) | 0.3568 |  |  |
Penetrating or stricturing CD | 2.07 (1.40–3.07) | 0.0003 |  |  |
Ileocolonic | 1.09 (0.74–1.61) | 0.6464 |  |  |
EIMs | 1.82 (1.33–2.49) | 0.0002 | 1.79 (1.27–2.52) | 0.0008 |
Major disease surgeries | 2.15 (1.43–3.23) | 0.0002 | 1.73 (1.07–2.78) | 0.0257 |
IBD hospitalizationsa | 2.39 (1.56–3.66) | 0.0001 | 1.96 (1.25–3.09) | 0.0035 |
Immmunomodulators | 1.20 (0.89–1.64) | 0.2346 |  |  |
Anti-TNF any time | 1.53 (1.11–2.12) | 0.0090 | 0.79 (0.55–1.14) | 0.2062 |
Other biologics at any time | 1.48 (0.82–2.68) | 0.1944 |  |  |